SCHEMBL3790221

SCHEMBL3790221

CCOC(=O)c1nc2c(Nc3ccccc3F)cccc2n2cccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.44
CDC25A P30304 1/20 0.44
CDC25C P30307 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
LMNA P02545 2/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3797276 0.87 POLB (0.42) CDC25BCDC25ACDC25CKDM4EALDH1A1
SCHEMBL3789561 0.83 CSNK2B (0.45) KDM4EMAPTTP53KMT2AMEN1
SCHEMBL3790215 0.81 PIM1 (0.50) CDC25BCDC25ACDC25CKDM4EALDH1A1
SCHEMBL3784901 0.77 SMN1; SMN2 (0.45) KDM4EALDH1A1MAPTSMN1; SMN2KMT2A
SCHEMBL1310922 0.75 PTPN2 (0.53) KDM4EALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL3794469 0.74 KDM4E (0.46) CDC25BCDC25ACDC25CKDM4EALDH1A1
SCHEMBL3587879 0.73 GUCY1A1 (0.52) KDM4EALDH1A1POLBSMN1; SMN2KMT2A
SCHEMBL3790258 0.72 LCK (0.55) CDC25BCDC25ACDC25CKDM4EALDH1A1
SCHEMBL28420937 0.71 POLB (0.49) CDC25BCDC25ACDC25CKDM4EALDH1A1
SCHEMBL16516735 0.70 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298302-A1 NOVEL PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298302-A1 NOVEL PROTEIN KINASE MODULATORS PIM2, PIM1, PIM3 CDC25B 460/4885CDC25A 459/4885CDC25C 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.